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ABSTRACT 
Background and Objectives: 
 Onychomycosis, a fungal infection of nail and are caused by 
dermatophytes, non dermatophytic moulds and the yeasts. It showed varied 
mycological and clinico epidemiological pattern in various part of the country. 
This study was carried out to document the mycological and clinico 
epidemiological pattern of onychomycosis in Coimbatore (South India), to 
analyse the sensitivity of mycological techniques (Microscopy and culture) and 
to carry out the anti fungal susceptibility testing of the isolates. 
Materials and methods:  
 Eighty five clinically diagnosed cases of onychomycosis attending the 
Dermatology Out patient Department of Coimbatore Medical College Hospital 
over a period of 15 months from April 2010 – June 2011 were taken for this 
study. Direct microscopy (40%KOH) and the fungal culture were done. Anti 
fungal susceptibility testing of the isolates were carried out by CLSI Broth 
microdilution method (M38 A & M27 A2). 
Results: 
 These 85 patients were between 6 – 65years of age. Men were commonly 
affected than Women with a ratio of 2.7:1. Distal and lateral subungual 
onychomycosis was the commonest clinical type (56.50%). Finger nails were 
commonly affected than toe nails (3.5:1).Majority of patients were farmers, 
office workers and housewives. The culture and microscopy positivity were 
recorded in 54.12% and 50.59% of cases respectively. Dermatophytes and Non 
dermatophytic moulds (NDM) were isolated in 28.2% and 15.3% of cultured 
nail samples while the Yeasts were isolated in 10.6% of nail samples. The 
dermatophytes were T.mentagrophyte (16.5%) and T.rubrum (11.8%). The 
commonest NDM was Penicillium species (10.6%) while other NDM were 
A.niger (2.4%), A.flavuus (1.2%) and Cladosporium (1.2%). Tenia corporis 
(8.7%) was the skin infection significantly associated with onychomycosis. In 
vitro susceptibility data of the isolates showed that Terbinafine has got the 
lowest MIC (≤ 0.03µg/ml) for all the filamentous fungi and fluconazole has got 
the lowest MIC (2 µg/ml) for the Yeast isolates.  
Conclusion: 
Onychomycosis is a signifigant health problem and shows varied clinico 
mycological pattern in this area. The role of NDM as the causative agents in 
onychomycosis is significant hence the accurate mycological diagnosis and 
appropriate treatment. 
Key words: Onychomycosis, Clinico – mycological pattern, invitro 
susceptibility. 
INTRODUCTION 
  Onychomycosis is a term used to describe fungal infection of nails caused by three 
groups of fungi namely dermatophytes, yeasts and non dermatophytic moulds. 
The word onychomycosis is derived from Greek - ‘onyx’, nail and ‘mykes’, fungus.
3, 31
 
 Onychomycosis affects 5% of the population worldwide representing 20-40% of 
onychopathies
 
and 30% of the mycotic cutaneous infections 
3, 4, 5
 The worldwide incidence of 
onychomycosis is increasing and a number of factors such as age, sex, occupation, climate, 
living condition, etc contributing to this rise. Clinical and mycological features of 
onychomycosis show variation with time and place.
4, 5, 7
  
 Previously regarded as contaminants, the yeasts and moulds are now increasingly 
recognized as pathogens especially in immuno compromised individuals like patients with 
diabetes, HIV/AIDS, steroid therapy and cancer chemotherapy
20 
   In onychomycosis, the infected nails serve as a chronic reservoir of infection which 
can give rise to repeated mycotic infection of skin, causing considerable disfigurement and 
lysis of nails leading to increased morbidity. The nail changes in onychomycosis mimic other 
nail disorders, such as psoriasis, chronic onycholysis, lichen planus, nail trauma, etc. So it is 
of significance to suspect onychomycosis, perform mycological diagnosis and undertake 
appropriate treatment.
17
 
 The fungal infections of nail do not respond well to treatment, the management of 
onychomycosis continues to be problematic despite the advent of newer antifungal agents. 
The duration of treatment is also very long which may lead to potential side effects, poor 
compliance by the patients and as a consequence, emergence of drug resistance.
21, 30, and 47 
 
 Successful treatment depends on the ability of the given antifungal to eradicate the 
fungal isolate. In order to predict this ability, in vitro susceptibility testing becomes helpful 
because it can help the clinicians to choose the appropriate drug for the treatment. 
 So it is advisable to obtain a definitive diagnosis by standard mycological techniques, 
to determine the various clinical patterns and to select appropriate antifungal drug for the 
treatment of onychomycosis by antifungal susceptibility testing, hence the study. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               AIM AND OBJECTIVES 
OVERALL AIM: To evaluate the mycological and clinico - epidemiological aspects of 
onychomycosis in Coimbatore District. 
Specific Objectives: 
1. To isolate and identify the fungi from the clinically diagnosed cases of 
onychomycosis by standard mycological techniques. 
2. To study the predominant fungi causing onychomycosis and their varied      clinico – 
epidemiological presentation in Coimbatore.  
3. To determine the MIC of anti fungal drugs for the filamentous fungi and yeast isolates 
by   CLSI M-38 A & CLSI M-27 A2 Broth micro dilution Method. 
4. To do the comparative evaluation of Microscopy and Culture in the laboratory 
diagnosis of onychomycosis. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
HISTORY 
 Mycology, the study of fungi which came into existence when Hooks in 1677 studied 
the yellow spots on the leaves of Desmark rose and found the filamentous organism with the 
help of magnifying lens. Subsequent studies were carried by Malphigi (1686), Mitchelli 
(1729) and Linnaeus (1752)
1
 
In 1835, Augustino Bassi was the first to elucidate the microbial nature of deadly 
disease of silkworms (Bombyx mori) and that a mould now known as Beauveria bassiana was 
the cause of disease of the commercially available silkworm. This was the first organism to 
be recognized evoking a disease.
1
 
 There have been few studies of incidence of onychomycosis in the general population 
(Grimmer et al, 1954; Langer et al, 1957).
2 
 
 In 1904, Dubendorfer described the candidal onychomycosis. Until late 1990s 
Onychomycosis was a poorly discussed topic in medical science. Even in developed 
countries, this infection has been high lighted only in the last decade.  
 Cases of onychomycosis represent 30% of diagnosed superficial fungal infections and 
are caused by three groups of fungi: dermatophytes, yeasts, and nondermatophytic moulds 
(NDM). The majority of toenail infections are caused by dermatophytes; Trichophyton 
rubrum is isolated with the greatest frequency. NDM represent 3% of the nail infections in a 
temperate country such as the United Kingdom but a much higher proportion in tropical 
countries.  
 
 
STUDIES ON ONYCHOMYCOSIS:  
 In October 1987 J. Andre, M.D., G. Achten, M.D., at University of Brussels, Belgium 
conducted a study on Onychomycosis showed that the dermatophytes are mostly responsible 
for onychomycosis. They isolated two anthrophophilic dermatophytes, T.rubrum, 
T.mentagrophyte var interdigitale with four times higher the incidence of the first pathogen
8 
 
In the largest series of 79 patients with SWO from Italy, in 1994 the most common 
pathogen was Trichophyton interdigitale (73%), followed by Fusarium species (11%), 
Aspergillus species (6%),Trichophyton rubrum (5%), and Acremonium species (3%). These 
percentages vary in different studies, but T.mentagrophyte var interdigitale is constantly 
highest on the list.
11, 12, 13
 
 Candida albicans was the predominant isolate in two studies (1999, RSN Brilhante et 
al at Northeast Brazil and M Gerami shoar et al 2001 at Tehran).In their studies finger nails 
were the most frequent anatomic site. Finger nails were affected more in women; where as 
predominant site involved in males were toe nails.
10  
 
INDIAN SCENARIO:  
 Various Indian workers have reported the incidence to be at 0.5 – 5% in the general 
Population
9
  
 In 1979 Prasad and Prakash
6
 conducted a study on onychomycosis at Ranchi, India. It 
showed the prevalence rate of 10.2% 
 In Jan2000, a five year study by Kaur et al  in among 400 patients of clinically 
suspected cases of nail infections at dermatology out patient department in New Delhi 
showed the presence of onychomycosis in 218 cases (54.5%) by culture and/or direct 
microscopy. Finger nails were the most frequent anatomical site (65%). Regarding 
filamentous non dermatophytic moulds,  Aspergillus species, Fusarium species, Alternaria 
species and the Penicillium species  were the most frequently isolated. Occasionally 
Bipolaris, Nigrospora, Curvularia, Scedosporium apiaspermum were isolated. The disease 
was most prevalent in the 25 -45 age group and the ratio of male to female patients was 
approximately 1:1.
7
 
 In 2003, Grover conducted a study of onychomycosis in 50 patients at Air Force 
Hospital, Bangalore in which  Dermatophytes grown in 14 (23.7%) cultures, NDM in 13 
(22%), candida in 10 (16.8%), no growth in 22 (37.2%). Commonest species among 
dermatophyte was T.rubrum. Among NDM Aspergillus spp was most common isolate.
22 
 In North India a three year study in April 2004 by Smita Sarma, MD, showed the 
most common fungal isolates were dermatophytes (49.5%), followed by Candida spp 
(40.4%). Of the dermatophytes, Trichophyton rubrum (47%) was the most common isolate, 
followed by Trichophyton tonsurans (20.4%). Of the Candida spp., Candida albicans was the 
most common (60%). Distal and lateral subungual onychomycosis was the most common 
clinical pattern (62%), followed by total dystrophic onychomycosis (20.2%).
15
 
 In January 2005, Veer et al conducted a study at Skin and VD, OP department of 
Government Medical College and Hospital, Aurangabad from 88 suspected cases of 
onychomycosis. Direct microscopy was positive in 72 (81.8%) and culture was positive in 43 
(48.8%) cases. Culture results showed growth of dermatophytes in 26 (29.5%) cases, NDM in 
12 (13.6%) and Candida spp. In 5 (5.6%) while 45 (51.1%) yielded no growth. Among 
dermatophytes, T.rubrum was the commonest etiological agent followed by 
T.mentagrophytes. Among NDM, Aspergillus spp was the most prevalent followed by 
Alternaria spp, Curvularia spp, and Fusarium spp. Commonest age group affected was above 
31 years. Male to female ratio being 1.8 :1. Finger nails were more frequently than toe nails 
with the ratio of 3:1. DLSO was the more common clinical pattern (50%) followed by PSO 
(20.4%), SWO (2%), TDO (14%0 and paronychia (10.2%).
17 
 Gupta M et al, in 2006, conducted a study of 130 patients from OP department of 
Dermatology , Venerology and Leprosy at Indra Gandhi Medical College , Shimla, Himachal 
Pradesh, India showed that the prevalence of onychomycosis higher among farmers and 
office workers (20% each). Fingernails were commonly involved (56.9%). DLSO was the 
most common clinical type (73.1%).  Dermatophytes isolated were T.rubrum (32.6%), 
T.mentagrophytes (6.1%0 and T.verrucosum (2.1%). Aspergillus spp was the most 
commonly isolated NDM (6.1%) while other detected mold were Acremonium spp, Fusarium 
spp, Scopulariopsis spp, Curvularia spp and Penicillium marneffei. 
19 
 In 2007, a two year study by Adhikari et al from 34 clinically suspected cases of 
onychomycosis at Gangtok, Sikkim showed that trichophyton tonsurans (44.44%) was the 
commonest isolate followed by T. mentagrophytes (22.22%), T.rubrum (11.11%), 
T.verrucosum (11.11%) and M.audouinii (11.11%). Most common NDM isolated was 
Aspergillus niger (21.43%) followed by Penicillium  marneffei (14.28). Direct microscopy 
for fungal elements was positive in 32 (94.12%) cases and 28 (82.35%) cases were positive 
for culture. Commonest age group affected was 21 – 30yrs. Male to female ratio was 
1.125:1.
20
  
  Kaur et al in 2008 conducted a study at Maulana Azad Medical College, New Delhi 
from 60 patints of clinically suspected cases of onychomycosis. The study showed tthat 
T.rubrum was the commonest isolate (46.67%). T.mentagrophytes and Candida albicans 
accounted for 20% and 15.56% isolates, respectively. Isolation rate was higher by drilling 
compared to scraping, the rates being 83.33% and 66.67%, respectively. The highest 
incidence was found in the age groups between 21 – 30 years. The disease was more common 
in males. Finger nails were most commonly involved than toe nails.
18 
 In 2008, a study by Das et al in Kolkata from 85 cases of onychomycosis showed the 
culture growth of fungus in 44 (51.76%) cases. Predominant agents were dermatophytes  - 
T.rubrum (29.54%)  species being most common. Aspergillus niger  (18.18%) among NDM 
was the most common isolate. Candida albicans (11.78%) was the predominant yeast
21. 
Positive results were more with culture (94.45%) than with KOH preparation (63.64%) 
21
 
ROLE OF NON DERMATOPHYTIC MOULDS AND YEASTS IN 
ONYCHOMYCOSIS: 
 With the increasing number of immuno compromised patients, many species of fungi 
originally regarded as laboratory contaminants are now considered to be agent of 
onychomycosis and may sometimes also affect immuno competent patients. (Guilhermetti et 
al).
25
  
 Malasaaesia furfur has also been reported as one of the NDM causing onychomycosis. 
(Silva V et al, Turkey, 1997) 
  Gibas et al in 2002, identified Onychocola kanei sp. nov., by DNA analysis at 
University of Toranto, Canada.
27 
 
  In 2005, Pontarell et al, reported Sytalidium dimidiatum from two cases of 
onychomycosis in Santa Catarina, Brazil
29
 
 In a study of 250 HIV infected patients at Mumbai by Surjushe A et al in 2007 
showed microscopy postitivity in 49 cases, culture growth in 32cases. Most common clinical 
type – TDO i.e. in 33 (55%) cases, followed by DLSO in 21 (35%) cases, PSO in 5 (8.33%) 
cases, SWO in one case. Commonest agents isolated were NDM, in 19 (31.66%) patients 
followed by dermatophytes in 13 (21.66%) patients. Of the NDM, Aspergillus nigar was the 
commonest isolate and other NDM agents isolated were Cladosporium spp., Sctalidium 
hyalinum, Penicillium spp., and Gymnoascus dankaliensis. 
24 
 In 2008, Hafidh reported Cladosporium spp., as the causative agent of white 
superficial onychomycosis in University of Bagdad, Iraq. Other non dermatophytic molds 
identified in his study of toe nail onychomycosis were Alternaria spp., Aspergillus spp.
28
 
 A new species, Aspergillus persii was isolated as the causative agent of 
onychomycosis by Zotti et al in 2009 at University Genoa, Italy. 
26
  
Summerbell et al suggested that non dermatophytic moulds and yeasts identified in nail tissue 
may be considered as one of the following: 
1. Contaminant ( species gowing in culture from dorman pars of nails) 
2. Normal mammalian surface commensal organism 
3. Transient saprophytic coloniser 
4. Persistent secondary coloniser (coloniser of material infected by dermatophyte but 
incapable of remaining after the dermatophyte is eliminated ) 
5. Successional invader ( species that can cause infection after gaining entry in to     a 
nail via the disruption caused by primary pathogen ) 
6. Primary invader (able to infect and cause onychomycosis in a previously uncolonised 
nails) 
1. Definitive diagnosis of non dermatophytic invasion of nails can be done by  
 “WALSE AND ENGLISH” (1966, UK) criterion 
2, 55
 
• Microscopy positive for fungal elements   
                                    And                                                              
• Culture also positive for NDM or yeast with the absence of concomitant   
dermatophytic growth with atleast five inocula give rise to same growth from same 
specimen inoculated at different places on culture media. 
 
 
 
2.  It has later been modified by Summerbell et al in 2002.
55
 According to this criterion,        
• Microscopy positive for fungal elements     
                                        And                                                                         
• Repeated isolation of the same fungus from the same specimen on successive two or 
more occasions at an interval of one week 
NATOMY OF NAIL 
 The nail unit includes the nail plate, matrix, nail bed, proximal & lateral folds, 
hyponychium, and underlying distal phalanx. The components of the nail apparatus in shown 
diagrammatically in figure1 
            Figure 1.Longitudinal section of a digit showing the dorsal nail apparatus 
 
                                    
 
Nail plate:  
 It is flat, roughly rectangular, slightly convex horny plate, having two lateral, one 
distal and one proximal edge.    
Lateral nail folds:  
 They are the cutaneous folded structures providing the lateral borders to the nails. 
Proximal nail fold:  
 This is cutaneous folded structure providing the visible proximal border of the nail, 
continuous with the cuticle.  
 
Cuticle:  
 It is the horny layer extending from the dorsal and ventral aspect of the proximal nail 
fold and adhering to the dorsal aspect of the proximal nail fold.  
Lunula:  
 It is the convex margin of the distal matrix seen through the nail. It is paler than 
adjacent nail bed. It is most commonly visible on the thumbs and great toes. It may be 
concealed by the proximal nail fold.  
Nail bed:  
 The vascular bed upon which the nail rests extending from the lunula to the 
hyponychium. This is the major territory seen through the nail plate. The nail plate is firmly 
bonded to the nail bed, less so proximal to the lunula margin. 
Hyponychium: The cutaneous margin underlying free nail. In this region the separation of 
the nail plate and nail bed begin 
                                                      MYCOLOGY 
 Onychomycosis was traditionally referred to non dermatomatophytic fungal infection 
of nail but now used as general term to denote all fungal infections of nails. Tinea unguium 
specifically describes dermatophyte invasion of nail.  
Classification of causative agents involved in onychomycosis
15, 31
 
A. DERMATOPHYTES  
 Trichophyton rubrum 
            Trichophyton mentagrophyte 
 Epidermophyton floccosum 
  Trichophyton tonsurans 
 
B. NON DERMATOPHYTIC MOULDS 
 Scopulariopsis brevicaulis 
 Acremonium spp., 
 Aspergillus flavus and A. fumigatus 
 Fusarium oxysporum 
 Scytalidium dimidiatum 
 Scytalidium hyalinum 
 Onychocola Canadensis 
 Geotricum candidum 
 Culvularia lunata 
 Alternaria species 
 Penicillium species 
C.YEAST LIKE FUNGUS: 
 Candida albicans  
Microscopic and macroscopic features of each species: 
31, 32 
DERMATOPHYTES: 
 These group of fungi are characterized by smooth thin walled pencil shaped 
macroconidia. Microconidia are spherical or club shaped. 
1. Trichophyton mentagrophytes: 
Macroscopic features:  
 The growth is rapid forming creamy tan to pink surface, with white, powdery to 
granular consistency. Reverse is buff to red or reddish brown. 
 
 
Microscopic features:  
 Smooth walled pencil shaped macroconidia. Abundant spherical microconidia 
arranged in grape like clusters. 
2. Trichophyton rubrum: 
Macroscopic features:  
 A granular or fluffy white colony with a pink periphery and deep wine red reverse 
forms in two weeks. 
Microscopic features:  
 Numerous or few smooth walled pencil shaped macroconidia. Numerous club shaped 
microconidia are borne singly along the sides of the hyphae. 
B. NON DERMATOPHYTIC MOULDS: 
1. Penicillium species:  
Macroscopic / colony morphology:  
 Colonies are granular and generally with various shades of green, although yellow- 
brown colonies may be seen. Wine red pigment diffusing into the agar is seen in case of 
Penicillium marneffei. 
Microscopic features:  
 The penicillous or brush shaped conidiophore is produced and it’s branched into 
metulae, phialides from the tips of which chains of conidia are produced, tips of phialides are 
blunt. Conidia are spherical and regular in size and acrepetal type.  
 2. Aspergillus niger: 
Macroscopic / colony morphology:  
 Surface of the colony is covered with dense “jet black” conidia, giving characteristic 
pepper effect.  
 
Microscopic features:  
 Dense aggregates of single and short chains of jet black conidia that usually cover the 
entire vesicle. They are biseriate. (Double row of phialides). 
 
3. Aspergillus fumigatus: 
Macroscopic / colony morphology:  
 The colonies have shades of blue grey, green-grey, green- brown pigmentation 
Microscopic features:  
 Single row of phialides over the top half of the vesicles. Conidia are arranged in long 
chains with bending towards central axis.  
4. Aspergillus flavus : 
Macroscopic / colony morphology:  
 Colonies are granular, yellow, yellow green or yellow brown. 
Microscopic features:  
 Daisy petal like arrangement of chains of conidia with single or double row of 
phialides.   
C. YEAST LIKE FUNGI: 
Candida albicans: 
Macroscopic / colony morphology: Creamy, smooth colonies. 
Microscopic features:  
Gram stain      : Gram positive budding yeast cells. 
EPIDEMIOLOGY: 
 The prevalence of onychomycosis ranges from 2 – 3% to 13% in the Western 
Countries in contrast to South East Asia whree the prevalence is very low. In India, the 
prevalence rate varies from 0.5 to 12.5% from different studies in  different part of the 
country.
30 
 The prevalence rate is determined by age, predisposing factor, social class, 
occupation, climate, etc. Several studies have shown that the prevalence increases with age, 
reasons for which may include poor peripheral circulation, diabetes, repeated nail trauma, sub 
optimal immume system, poor self care. The disease prevalence is higher in HIV patients.
7 
 In one study in New Delhi, India revealed that the prevalence was confirmed in 45% 
of the analysed patients.
7 
 HOST FACTORS: 
 Number of host factors like diabetes, Immuno compromised states like patients with 
AIDS, on immuno suppressive therapy, cancer chemotherapy, and steroid use all have 
contribution to onychomycosis particularly by non dermatophytic fungi.
7
  
 Because of the above mentioned factors, non dermatophytic moulds and yeasts once 
regarded as contaminants are now increasingly reported as pathogens in finger nail and toe 
nail onychomycosis.
5
    
 Onychomycosis in adults is mainly by trauma due to increased out door activities, 
those wearing occlusive foot wear especially in business peoples and executives, office 
workers.  
 Onychomycosis is more common in males from most of the studies in various parts of 
the world.
17, 19, 20
Candidal onychomycosis is more common in females (house wives, cooks) 
which may be attributed to the frequent immersion of hand in water.
35 
ENVIRONMENTAL FACTORS: 
 Living environment and climate have great impact on onychomycosis.
5
The disease is 
lower in tropical countries (3.8%) than in subtropical countries and countries in the temperate 
zone (18%).
33
 
                                     CLINICAL FEATURES 
 Onychomycosis, the fungal infection of nail affects all age group, both sexes. It 
affects toenails as well as fingernails. Toe nail onychomycosis is more common than 
fingernails except few cases. 
CLINICAL TYPES: 
1. DISTAL SUBUNGUAL ONYCHOMYCOSIS (DLSO): 
 It is the most common type of clinical presentation in which there is invasion of nail 
bed and underside of the nailplate. It has two consequences – onycholysis and subungual  
hyperkeratosis. The dermatophytes are the predominant causative agents.  
2. PROXIMAL SUBUNGUAL ONYCHOMYCOSIS (PSO):  
 It is relatively uncommon type; organisms invade the nail via proximal nail fold 
through the cuticle area, penetrating newly formed area and migrate distally. Periungual 
inflammation is marked and painful, in some cases associated with purulent discharge. These 
patients are frequently misdiagnosed as bacterial having bacterial infections. It is increasingly 
reported in AIDS patients. Most common species involved is Candida. 
3. WHITE SUPERFICIAL ONYCHOMYCOSIS (WSO):  
 This is surface infection of nail primarily when fungi invade superficial layers of nail 
plate directly and is caused by T. mentagrophuytes. 
4. TOTAL DYSTROPHIC ONYCHOMYCOSIS (TDO): 
 There is total destruction of nail plate, which usually occurs as a result of infection by 
dermatophytes. 
5. CANDIDAL ONYCHOMYCOSIS:   
 These are mostly caused by Candida albicans.  
        
 
Figure 2: Distal and lateral subungual onchomycos
 
 
                     
 
                                   
 
 
 
 
Figure 3: Proximal subungual onychomycosis (PSO)
 
 
 
 
 
 
 
                        
 
 
 
 
is (DLSO) 
 
 
 
 Figure: 4 Superficial White Onychomycosis (SWO)
 
 
 
 
 
 
 
 
Figure: 5 Total Dystrophic 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Onychomycosis (TDO) 
 Figure: 6 Candidal Onychomycosis with pseudoclubbing
 
 
 
 
                        
 
 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
Figure: 7 Onycholysis 
 Figure: 8 Sub ungual hyperkeratosis
                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LABORATORY DIAGNOSIS: 
 Detailed clinical examination of lesions can be done in bright light. Clinical lesions 
produced by these fungi are highly variable and closely resembles other non infectious nail 
disorders, making laboratory diagnosis and confirmation necessary. 
Differential diagnosis for onychomycosis are psoriasis, lichen planus, contact dermatitis, 
traumatic onychodystrophies, paronychia congenita, nail bed tumour, yellow nail syndrome, 
idiopathic onycholysis, bacterial infections etc.
7
   
Samples are divided into two portions. One part is used for culture and other portion is used 
for microscopy.  
Microscopy:  
40% KOH is used. 
Modification of KOH for rapid visualisation of fungus:  
 (i) Addition of superchrome parker blue-black ink or some comparable substance to KOH 
solution. The ink selectively colours the hyphae, making them more pronounced. But it may 
take longer time to stain. 
(ii) Addition of 36% dimethylsulphoxide (DMSO) to 20% or 40% KOH aids in penetration of 
specimen but over-digestion is a problem and the specimen has to be examined within 1-2 
hour. Dimethylacetamide or dimethylformamide are used as alternatives. 
(iii) Addition of 10-25% glycerine to KOH preparation to delay crystallization of KOH, 
degradation of fungus and rapid dehydration. 
An alternative clearing agent, which does not require warming of specimen is 20% sodium 
sulphide solution. 
 
 
 
Cultural isolation:  
 Samples are inoculated into two sets of culture media – Sabouraud’s dextrose agar 
with chloramphenicol and Sabouraud’s dextrose agar with chloramphenicol and 
cycloheximide. Tubes are incubated at 25
0
 - 30
0
C and at 37
0
C. Most of the dermatophytes 
and non dermatophytic moulds will grow at the optimum temperature of   < 30
0 
C. Candida 
spp will grow at 37
0
C. Cycloheximide inhibits the growth of most of the saprophytic fungi 
without inhibiting the growth of dermatophytes.  Therefore Sabouraud’s dextrose agar with 
chloramphenicol and cycloheximide  medium  is used as primary media for the isolation of 
dematophytes.  
Routine incubation has traditionally been done for four weeks. Cultures should be examined 
at least every 2 – 3 days for the first two weeks and weekly thereafter. 
1. Sabouraud’s dextrose agar with chloramphenicol: 
 Sabouraud’s dextrose agar with chloramphenicol (0.05%) inhibits the growth of 
bacteria without deterring the growth of filamentous fungi and yeast 
2. Sabouraud’s dextrose agar with chloramphenicol and cycloheximide: 
 The standard medium for growing dermatophyte is Sabouraud’s dextrose agar 
containing chloramphenicol and cycloheximide, which inhibit bacteria and saprophytic fungi 
respectively. The cycloheximide (Actidione) in a concentration of 0.5 mg per ml suppresses 
the growth of most saprophytic fungi such as Scytalidium, Hendersonula, Aspergillus, 
Candida species without deterring the growth of dermatophytes. The various antibacterial 
antibiotics used include chloramphenicol (0.05 mg/ml) or gentamicin (0.1 mg/ml).  
3.  Potato dextrose agar: 
 
 It induces sporulation in filamentous fungi and can be used in slide cultures and 
antifungal susceptibility testing. 
 
Identification by genus and species level: 
Isolated fungi are identified the following methods 
1. Colony morphology (obverse and reverse sides): 
(i) Colony obverse:  
 The colour (white, pearl, ivory etc), texture of the surface (glabrous or waxy, 
powdery, granular, suede-like velvety, downy or fluffy). 
(ii) Colony reverse:  
 Presence or absence of pigment, whether diffusing into the medium or not and 
topography (flat, raised, heaped) and rate of growth. 
2. Lactophenol cotton blue mount (tease mount) 
3. Slide culture technique 
4. Cellophane or adhesive tape method 
5. Gram staining from culture:  
 Candida spp seen as Gram positive budding yeast cells 
6. Germ tube test:  
 This test is done to identify the Candida albicans species. Colonies of candida species 
are mixed with 0.5 ml of human serum or other suitable colloid in a sterile test tube. The tube 
is incubated at 37
0
C for 2-3 hours. A drop of this mixture is kept over a microscope slide. It’s 
covered with coverslip and examined for the production of germ tube – tube like projections 
from the yeast cells with out any constriction at the base. (Constriction at the base is seen in 
pseudo hyphae production). Germ tubes are true hyphal extensions. However 5% of Candida 
albicans will not produce the germ tube formation.  
7. Physiological parameters:  
 Because of inconsistency in the development of several of the characteristic 
morphological features by these fungi and also due to infrequent 
production of reproductive forms, some physiological criteria are often relied upon for a 
definite identification. These include 
i) Urease Test:  
 A distinction between T. rubrum and T. mentagrophytes (particularly slow pigment 
producing varieties) is achieved by testing the strain for urease production. Both 
Christensen’s urea agar and broth may be used. The test is positive in T. mentagrophytes and 
negative in T. rubrum. 
ii) Pigment Production:  
 Generally T. rubrum isolates produce a dark cherry red colour under the colony. 
Confusion exists in differentiation of many slow pigment producing varieties of this species 
and similar isolates of T. mentagrophytes. For this purpose, stimulation of pigment 
production has been achieved by growing them on potato-dextrose agar and cornmeal 
dextrose agar media. 
iii) Hair perforation Test:  
 The test was devised to distinguish between atypical isolates of T. mentagrophytes 
and T. rubrum. T. mentagrophytes produce hair perforating organs that penetrate hair radially 
and cause wedge shaped perforation where as T. rubrum do not. A sterile filter paper strip is 
placed into bottom of petridish with sterile distilled water. A small portion of sterilized 
prepubertal or infant hair is added into water.  5-6 drops of1% yeast extract is added to speed 
up reaction. Inoculate colony directly on hair and incubate at 25˚C for four weeks. Observe 
hair by making a wet smear for presence of conical perforations of hair shaft.
36
  
 
 
 
 
TREATMENT OF ONYCHOMYCOSIS: 
Antifungal agents: 
Anti fungal antibiotics: Griseofulvin 
 It inhibits fungal mitosis by interference with polymerized microtubule and spindle 
formation in dividing cells. It is a fungi static drug.
31 
Allylamines:  
 These agents selectively inhibit the key enzyme squalene epoxidase which is required 
for fungal ergosterol biosynthesis and leads to accumulation of squalene which leads to 
weakening of cell membrane and cell death. Terbinafine is an allylamine, having high 
potency against nail infections shown by its very low MIC values. The fungicidal property, 
combined with its ability to penetrate rapidly into the nail plate, making it as a short course 
treatment drug which is feasible with a low potential for relapse. 
Azoles: 
  The principal mode of action of the azole is the inhibition of cytochrome P-450 
dependent C14 demethylation step. The important azoles used in the treatment of 
onychomycosis are ketoconazole and the newer triazoles fluconazole, itraconazole, 
voriconazole. Ketoconazole carries the risk of hepatotoxicity. 
Topical antifungal agents: 
 They are used in fungal nail infections along with systemic agents. Ciclopiroxolamine 
8% nail lacquer, amorolfine 5% nail lacquer and topical acidified nitrite.
37, 38 
 
 Among oral antifungal agents, terbinafine is the drug of choice for tinea unguium. It is 
less effective against non dermatophytic infections, including Candida species and moulds. 
Fluconazole has a broad antifungal spectrum against dermatophytes, non dermatophytic 
moulds and Candida species particularly when used in pulse therapy. Itraconazole is the most 
effective drug for the treatment of candidal onychomycosis. Onychomycosis in children is 
better treated by topical antifungal agents and are used as the first choice of treatment.
39 
 
ANTI FUNGAL SUSCEPTIBILITY TESTING: 
 The antifungal susceptibility is performed to provide the clinician to select an 
appropriate antifungal agent for treating a particular fungal infection.
 31
 However, these 
testing are not recommended as routine procedure.  
 
 The National Committee for Clinical Laboratory Standards (NCCLS) M38 - A and 
M27 – A which describes the standard parameters for testing MIC of established agents 
against filamentous fungi and yeasts respectively. M38 – A has latter been modified for 
testing dermatophytes M-38-P with several important factors, such as temperature (28 versus 
35ºC) and time of incubation (4 to 10 days versus 21 to 72 hours).
 40
  
 
 In vitro susceptibility testing of fungi, is influenced by a number of factors such as 
inoculum size, culture medium composition, pH, and duration and temperature of incubation 
and MIC end point determination. The trailing end point observed with the azoles is another 
major problem encountered in the susceptibility testing of the fungi. 
31 
 
 Antifungal susceptibility testing is receiving increased attention with the advent of 
newer anti fungal drugs. However susceptility testing of filamentous fungi is not as advanced 
as susceptibility testing of Yeasts. In vitro susceptibility tests should provide a reliable 
measure of relative activity of the anti fungal agent, correlate with in vivo activity and predict 
the likely outcome of the therapy. 
41
 Several studies have attempted to correlate the MIC 
results with outcome.  
 The retrospective nature of the studies, the documented variability of the 
nonstandardized in vitro methods and the difficulty in defining mycoses and their responses 
to therapy are responsible for this status. 
42 
 
 Other methods that have been used for performing anti fungal susceptibility testing 
are disk diffusion method, Etest, Fungi test, spectrophotometric methods and flowcytometry. 
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                                           MATERIALS AND METHODS 
 
STUDY DESIGN: Prospective cohort study 
The present study was conducted at Department of Microbiology at Coimbatore 
Medical College and Hospital, Coimbatore. 
STUDY PERIOD:  
Over a period of 15 months from April 2010 to June 2011. 
SAMPLE SPECIFICATION:  
Nail clippings, nail scrapings and sub ungual scrapings were collected from eighty 
five patients who attended the Dermatology outpatient Department at Coimbatore Medical 
College Hospital, Coimbatore. 
INCLUSION CRITERIA: 
All patients with clinically diagnosed onychomycosis, irrespective of age and sex 
were included in this study. 
EXCLUSION CRITERIA: 
All patients who are under treatment with antifungal drugs in the previous one month 
period were excluded from the study. 
STUDY OF SELECTED CASES: 
The selected cases were studied as per the proforma enclosed. A detailed history of 
selected cases was taken in relation to name, age, sex, address, occupation, duration of 
illness, associated skin and systemic infections. 
After the detailed history, clinical examination of patient was made in good light 
which included site of nail involvement, number of nail units involved and the clinical type. 
 
METHODOLOGY: 
SPECIMEN COLLECTION: 
The affected area of the nail was thoroughly cleaned with 70% alcohol to remove 
surface contaminants .The alcohol was allowed to dry by evaporation.  The nail clippings and 
scrapings were taken by using sterile 15 No scalpel blade, from the advancing edges of 
diseased parts of the nails depending on the clinical type.
34
The scalpel blades were sterilised 
in autoclave at 121
o
C in 15 lbs for 15 minutes.  
TRANSPORT OF SAMPLES:  
The samples were collected and transported in a sterile dry container to the laboratory. 
PROCESSING OF SPECIMENS: 
Direct microscopic examination: 
Part of nail samples were immersed in 40% KOH and examined under low and high 
power of microscope after 24 – 48hrs for the presence of septate branched fungal hyphae / 
yeast cells 
Modification of 40% KOH with DMSO: 
Part of nail samples were immersed in solution of 40% KOH with DMSO and 
examined after one hour. The composition and preparation of the solution is attached in 
appendices. This method eliminated the need for waiting microscopic results for 24 – 48 hrs. 
Culture:   
After direct microscopic examination, irrespective of demonstration of fungal 
elements, the nail fragments were inoculated onto two sets of culture media, one containing 
Sabouraud’s dextrose agar with 0.05% chloramphenicol, other containing Sabouraud’s 
dextrose agar with 0.05% chloramphenicol and 0.5% cycloheximide. 
One set of culture media was incubated at 37
o
C and another set at 25 -30
o
C for a 
period of four weeks. Culture slopes were examined for fungal growth daily in the first week 
and twice weekly from 2
nd
 week onwards  
Definitive diagnosis of non dermatophytic invasion of nails was done by  
“WALSE AND ENGLISH” criteria (1966) 
2, 50
, i.e. 
1. Microscopy positive for fungal elements                                                                
                                                          And 
 Culture also positive for NDM with the absence of concomitant dermatophytic 
growth with at least four to five inocula give rise to same growth from same specimen 
inoculated at different places on culture media. 
 
Fungal isolates were identified based on colony morphology, pigmentation, 
microscopy (LPCB), slide culture, urease test (to differentiate T.mentagrophyte (positive) and 
T.rubrum (negative))  
Macroscopic examination of culture: 
The growth on Sabouraud’s dextrose agar was examined to study the colony 
morphology based on following characteristics. 
1. Colony characters on obverse:  
The colour and consistency of colonies were studied. Regarding dermatophytes and 
yeasts growth were present on both SDA ie ( chloramphenicol with/without cycloheximide) 
slopes. Where as NDM were grown on SDA slope without cycloheximide with the exception 
of penicillium spp which was cycloheximide tolerant. 
Observation:  
• Dermatophytes produced cottony white (T.mentagrophyte) and granular tan coloured 
(T.rubrum) colonies.  
• Penicillium spp gave rise to green – grey suede like colonies.  
• Aspergillus niger produced jet black colonies with pepper powdery growth. 
• Aspergillus flavus gave rise to greenish velvety colonies. 
• Candida spp produced creamy white smooth colonies. 
 
2. Colony characters on the reverse:   
Observed for the presence or absence of pigment, whether diffusing or not.  
Observation: 
• Few isolates of T.rubrum produced characteristic reddish brown pigment on reverse 
which diffused in to the medium. 
Microscopic examination of culture: 
a. LPCB mount:  
A portion of aerial mycelium was removed and placed in a drop of lactophenol cotton 
blue over a glass slide. The matted mycelial mass was gently teased with a pair of teasing 
needles and the cover-slip was placed on it. The tease mount was observed under low and 
high power objective of microscope, for the presence of hyphae, macroconidia, microconidia 
and other accessory structures of vegetative hyphae and the characters of each was noted.  
b. Slide culture:  
Preparation of the petridish for slide culture: 
Sterile petridish was taken and a piece of filter paper was cut according to the shape 
of petridish and placed inside the petridish. A ‘V’ tube was placed on the filter paper and a 
clean glass slide was placed over the ‘V’ tube and 1-2 cover-slips were placed inside. 
Petridish was closed with the lid, wrapped with paper and sterilized using hot air oven.  
Procedure: 
Blocks of (1 x 2 cms) Sabouraud’s dextrose agar and corn meal agar were cut using 
sterile scalpel blade. One such block from both was transferred on to glass slide supported on 
‘V’ tube in a petridish. Corners of the agar block were inoculated with the fungal colony 
using spud. A cover-slip was placed on surface of agar block using sterile forceps. Little 
amount of sterile distilled water was added to the petridish and the lid closed and incubated at 
room temperature. After each day the slide was taken out of petridish and examined under 
microscope without disturbing the cover-slip. 
When the sporulation was well evident, cover-slip was carefully removed from the 
agar block and placed on a drop of lactophenol cotton blue stain taken on a separate 
glass slide.  
One or two drops of lactophenol cotton blue were placed on the slide with fungal 
growth and cover-slip placed on it. Both the slides were examined under microscope. 
Character of hyphae, size, shape and arrangement of macroconidia, microconidia and other 
accessory vegetative structures were studied.  
Advantage of slide culture over tease mount technique is that it allows the study of 
microscopic features of fungus preserving the continuity between the hyphae, microconidia 
and macroconidia.  
c. Urease test:  
This test was done on Christensens’urea medium.  This was done to diffentiate 
T.mentagrophytes from T.rubrum. T,mentagrophytes strains, hydrolyse urea and the medium 
becomes deep red while T.rubrum does not hydrolyse urea.  
 
 
 
CANDIDA SPECIES IDENTIFICATION: 
a. Colony appearance:  
Creamy white, smooth moist colonies were observed on SDA with chloramphenicol 
slope. 
b. Microscopy – Gram stain:  
Thin smear was made from the culture growth on a clean, grease free glass slide, 
stained with Grams stain, air dried and examined under microscope for the presence of Gram 
positive budding yeast cells. 
c. Germ tube test:  
Germ tube test was done for the presumptive identification of Candida albicans 
species. 0.5ml of human serum was taken in a sterile test tube. To that added small portion of 
Candida culture and incubated at 37
o
C for 2- 4 hrs. A drop of this suspension was placed on a 
slide. A coverslip was put and examined under low power, high power of microscope for the 
presence of germ tubes. These are tube like extensions from the yeast cells, without any 
constrictions at their point of origin (base). 
 
 
 
 
 
 
 
 
 
 
 ANTI FUNGAL SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI AND  
YEAST BY MODIFIED CLSI MICRO BROTH DILUTION METHOD (M38 – A & 
M27 – A)  
I. Test medium 
          RPMI-1640 (with glutamine, without bicarbonate, and with a pH indicator) is the 
medium recommended for the susceptibility testing of filamentous fungi. The medium should 
be buffered with MOPS (0.164 mol/L).  
 Procedure for making RPMI-1640 medium: 
• 10.4 g powdered RPMI-1640 medium (HIMEDIA). 
• 34.53 g MOPS buffer (HIMEDIA). 
1) Dissolved powdered medium in 900 mL of distilled water. 
2) Added MOPS, and stirred until dissolved. 
3) Adjusted the pH to 7.0 at 25 using 10 or 1 mol/L sodium hydroxide while stirring. 
4) Added additional water to bring the medium to a final volume of 1 L. 
II. Anti fungal stock solution and Drug dilution preparation: 
Anti fungal agents used: (SIGMA ALDRICH) 
Powder forms of, 
Griseofulvin (solvent: DMSO) 
Ketoconazole (solvent: DMSO) 
Fluconazole (solvent: Distilled water) 
Terbinafine (solvent: DMSO) 
Stock solution preparation: 
a) For water soluble drugs: FLUCONAZOLE 
• 1280µg/ml 
b) For water insoluble drugs:GRISEOFULVIN, KETOCONAZOLE and TERBINAFINE 
• 1600µg/ml 
Drug dilution preparation: For water soluble drugs: FLUCONAZOLE  
 
  
 
 
 
 
 
 
 
i) Labelled 10 test tubes 2–11. 
ii) Added the appropriate amounts of sterile RPMI to each tube as follows: 
• Added 1 mL of RPMI to tubes 2 and 11. 
• Added 0.5 mL of RPMI to tubes 3, 5, and 8. 
• Added 0.75 mL of RPMI to tubes 6 and 9. 
• Added 1.5 mL of RPMI to tube 4. 
• Added 1.75 mL of RPMI to tubes 7 and 10. 
• Finally discarded 1mL from tube 11. 
• When the dilutions have been prepared, each tube contains 1 mL. 
• Mixed well with a vortex mixer before each dilution step. 
 Preparation of micro dilution trays for water-soluble antifungal agents: 
 i) Placed the tubes containing the drug dilutions (1 mL each) in an organized fashion, going 
from the highest to the lowest drug concentration. 
ii) Prepared a 1:5 dilution by adding 4 mL of RPMI to each drug dilution tube and mix well 
with a vortex mixer 
iii) Using a dispensing device, transferred 0.1 mL from each of the drug dilution tubes to the 
appropriate wells of each microtiter tray. 
                   
 
 
 
               
 
 
 
 
 
 
 
• The concentration of the antifungal agent in each well is now 2 times the concentration 
needed after this step. 
iv) Added 0.2 mL of RPMI to the wells in column 1 and 0.1 mL to wells in column 12. These 
wells will serve as the negative (sterility) and positive (growth) control wells, respectively. 
Drug dilution preparation: for water insoluble drugs: GRISEOFULVIN, 
KETOCONAZOLE and TERBINAFINE  
• The dilutions of water-insoluble antifungal agents must be prepared by using dimethyl 
sulfoxide (DMSO)  
• It is important to prepare the stock solution and drug dilutions in the solvent to avoid 
dilution artefacts  
a) 
Labelled 9 (12 × 75 mm) tubes 3–11. 
b) Added appropriate amounts of DMSO to each tube as follows: 
• Added 0.5 mL of DMSO to tubes 3, 6, and 9 
• Added 0.75 mL of DMSO to tubes 4, 7, and 10 
• Added 1.75 mL of DMSO to tubes 5, 8, and 11 
c) Labelled the stock solution tube (1,600 µg/mL) as tube 2 
d) Transferred from tube 2, 0.5 mL to tube 3 and 0.25 mL to tubes 4 and 5 
e) Transferred from tube 5, 0.5 mL to tube 6 and 0.25 mL to tubes 7 and 8 
f) Transferred from tube 8, 0.5 mL to tube 9 and 0.25 mL to tubes 10 and 11 
g) Finally, discarded 1 mL from tube 11 
h) When dilutions have been prepared, all the tubes contain 1 mL. 
 Preparation of microdilution trays for water-insoluble antifungal agents 
a) Placed the tubes containing the drug dilutions (1 mL) in an organized fashion, from the 
highest to the lowest drug concentration and labelled a row of 10 tubes with the appropriate 
drug concentration. 
b) Prepared a 1:50 dilution by mixing 4.9 mL of RPMI with 0.1 mL from each drug dilution 
tube; mixed well with a vortex mixer. 
c) Using a dispensing device, transferred 0.1 mL from each of the final drug dilution tubes to 
the appropriate well in each microtiter tray. 
d) Added 0.2 mL of RPMI plus 2% DMSO to column 1 of the microtiter tray and 0.1 mL of 
RPMI plus 2% DMSO to column 12. These two wells will serve as the negative (sterility) 
and positive (growth control) control wells, respectively, for the microtiter tray. 
 
 
 
 
 
 
 
 
 
• The concentration of the antifungal agents in the wells is now 2 times the 
concentration needed. 
• The concentration of DMSO in the wells is now 2%.   
 
 
 
 
 
 
iii) Inoculum preparation – For filamentous fungi: 
 
 
 
 
 
 
 
 
 
 
 
a) Inoculum must be prepared from a conidium or sporangiospore suspension obtained from 
7-day cultures grown on potato dextrose agar at 25°C–28°C. Some isolates need longer 
incubation (more than 7 days) to produce conidia. 
b) Recovered conidia by wetting surface of the colony with sterile normal saline and 
transferred the loopful of conidia into 3 mL of sterile saline. 
c) Vortex the conidia suspension vigorously for 15–20 s to prevent clumping of the spores.  
d) Allowed the heavy particles to settle for 3–5 min, and then transferred the upper 
suspension to a sterile tube and adjusted the turbidity using 0.5McFarland standard. 
e) Prepared a working suspension by diluting 1:50 of the conidia stock suspension in the 
standard medium (200µL of stock suspension into 10mL of RPMI), mixed well with a vortex 
mixer.  
 
 
B) For Yeast: 
                
 
 
 
 
 
 
 
 
 
 
 
iv) Inoculation of microtiter trays: 
Fill each row of the microtiter tray from wells 2–12 with 0.1 mL of the working inoculum 
suspension using a single or a multichannel pipette  
Incubation 
MIC trays were incubated in incubator at 35°C for 46–50 h for most of the opportunistic 
moulds and yeast 
 v) Reading & Interpretation: 
Visual reading: 
1) Removed the trays from the incubator. 
2) Placed the tray on a reading device (mirror reader) 
3) The growth control well must have sufficient growth. 
4) If adequate growth is not present, the trays were reincubated. Adequate growth will depend 
on the species being tested. 
5) Determine the MIC endpoints – MIC50 & MIC90. 
MIC50 - the lowest drug concentration that prevents any discernible growth (visually clear) 
in 50% of the strains when compared to the GC strain. 
MIC90 - the lowest drug concentration that prevents any discernible growth (visually clear) 
in 90% of the strains when compared to the GC strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure9: MICROSCOPY (40% KOH)  
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Shows Septate hyphae 
Shows Chlamydospore 
TRICHOPHYTON RUBRUM
                           
Figure10: Culture (Obverse & Reverse)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Figure11: LPCB mount 
 
Shows Redpigment on Reverse 
Shows Microconidia 
Shows Macroconidia 
 
TRICHOPHYTON MENTAGROPHYTE
 
Figure12: Culture (Colony Obverse & Reverse)
 
            
 
 
 
 
 
 
 
                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure13: LPCB mount 
 
 
 
 
 
Shows Spiral hyphae 
                                                PENICILLIUM SPECIES
 
                                 Figure14: Culture (Colony Obverse & Reverse)
   
     
 
 
                                                 Figure15: LPCB mount
 
 
 
 
 
 
                                            
                                                      
                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shows brush shaped conidia 
                                             
                              
Figure16: Culture (Colony Obverse & Reverse)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASPERGILLUS NIGER 
 
Figure17: LPCB mount 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure18: Culture (Colony Obverse & Reverse)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                         
 
 
 
 
 
 
ASPERGILLUS FLAVUS 
 
Figure19: LPCB mount 
 
Shows Single row of phialides with conidia 
covering 2/3 of vesicle 
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Shows Pigmented hyphae 
Shows Intercalary swelling 
LADOSPORIUM SPECIES 
Figure20: Culture 
Figure21: LPCB mount 
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Figure23: Gram stain                                               Figure24: Germ tube test
 
 
 
 
 
 
 
 
 
 
Shows Gram+ve yeast cells   
 
Figure22: Culture  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shows Germ tube
 
 
  
 
 
          
               
 
 
 
 
 
                                    
 
 
 
 
 
 
 
 
 
Figure26: Urease test 
                        
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
 
 
 
 
 
 
 
Figure25: Slide culture 
– T.mentagrophyte (+ve) & T.rubrum (-ve) 
SG      16    8      4      2      1       .5     25   .12     .06   .03  GC    
SG      16       8      4          2      1       .5      . 25    .12      .06    .03    GC    
Figure28: Antifungal susceptibility testing- MIC90 of Griseofulvin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Figure29: Antifungal susceptibility testing – MIC90 of Ketoconazole 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T.rubrum(16µg) 
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Figure30: Antifungal susceptibility testing – MIC90 of Fluconazole 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Figure31: Antifungal susceptibility testing – MIC90 of Terbinafine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T.rubrum(8µg) 
T.mentagrophyte (4µg) 
 
Candida (4µg) 
 
Penicillium (64µg) 
 
T.rubrum(.12µg) 
T.mentagrophyte (.03µg) 
 
Candida (16µg) 
 
Penicillium (.03µg) 
 
Aspergillus (.03µg) 
 
RESULTS 
 
 During the study period, a total of 85 cases with the clinical diagnosis of 
onychomycosis were studied by direct microscopy and fungal culture techniques. 
The statistical analysis of the variables was done by using SPSS software. P values were 
obtained from Pearson Chi Square test. 
 The age of the patients under study ranged from 6 – 65years. The commonest age 
group affected ranged from 41-50 years (28.30%) followed by 31-40years (18.18%) and 51-
60years (18.18%). Onychomycosis was less common in the age group below 20years (4.7%). 
(Ref: Table 1).  
 The male: female ratio was 2.7:1 with 62 (72.95%) cases of males and 23 (27.05%) 
cases of females. (Ref: Table 2). The highest incidence among males was observed in the 
age group 41 – 50years (20 cases), while among females it was 51 – 60years (8 cases). (Ref: 
Table 3). 
  Among all the age group, distal and lateral subungual onychomycosis (DLSO) was 
the commonest clinical pattern observed in 48cases (56.50%) followed by superficial white 
onychomycosis (SWO)12cases (14.1%), paronychia 10cases (11.8%) and total dystrophic 
onychomycosis (TDO) 9cases (10.6%). The less common clinical type was proximal 
subungual onychomycosis (PSO) 6cases (7%). (Ref: Table 4 & 5). 
 Regarding the site of involvement the fingernails were commonly involved 60cases 
(70.59%) than toe nails 17cases (20%). Finger nails and toe nails both were involved in 
8cases (9.41%). P value obtained for correlation of fingernail involvement and Paronychia 
type was 0.007. (Ref: Table 5). The nail changes observed in these cases were discolouration 
(100%), subungual hyperkeratosis (45%), nail thickening (22%) and onycholysis (18%). 
(Ref: Table 7) 
 The majority of patients were farmers (34.11%) followed by office workers (25.88%) 
and house wives (24.71%). The P value derived was 0.01(Ref: Table 6).  
 
 Small number of patients had other associated skin and systemic infections,  (18.9%). 
Skin infections were tenia corporis 7cases (8.7%), Psoriasis 2cases (2.35%), chronic eczema 
1case (1.2%) and Hansen’s disease 1case (1.2%). Systemic diseases were diabetes mellitus 
(1.2%), Systemic hypertension (2.35%), chronic kidney disease with chronic renal failure 
(1.2%) and AIDS on ART (1.5%). The P value derived for T.corporis correlation was 
0.05(Ref: Tab 8). 
 Out of the 85 clinically diagnosed onychomycosis, 60 cases (70.58%) were positive 
by microscopy (i.e., 40% KOH) and/or culture. 25 cases (29.41%) were negative by both the 
techniques. Total culture positive cases were 46 (54.12%). Total KOH positive cases were 43 
(50.59%). (Ref: Table 9).  
 The two microscopic techniques (KOH alone & KOH with DMSO) were compared. 
The sensitivity of both the techniques was 50.6% and 48.2% respectively while the P values 
calculated were 0.294 and 0.588. (Ref: Table 10) 
 The commonest fungi isolated in onychomycosis were dermatophytes 24  
(n =85, 28.2%) of which T.mentagrophyte was the commonest species 14/24 (16.5%) 
followed by T. rubrum 10/24 (11.8%). The non dermatophytic moulds (NDM) were the 
second common isolates, 13 (15.3%). Among the NDM, Penicillium species represented as 
the common species 9/13 (10.6%). Other non dermatophytic moulds isolated were 
Aspergillus niger 2/13 (2.4%), Aspergillus flavus 1/13 (1.2%) and Cladosporium species 1/13 
(1.2%). The third common group obtained were yeasts, the species being Candida albicans 9 
(10.6%). No growth was observed in 39 cases (45.9%). (Ref: Table 11)  
  
 The isolation rate was higher in males 33 (n = 46, 72%) than in females 13 (28%) for 
all the fungi with the exception of Penicillium species (9% in males, 11% in females) and 
Candida albicans (9% in males, 11% in females). It was also observed that finger nails 
yielded more number of isolates 35 (76%) than toe nails 8 (18%). The P value for Candida 
albicans isolate and the female patients was 0.085. 
(Ref: Tab 12 & 13). 
 The fungal isolates were tested for the susceptibility of four anti fungal drugs namely 
griseofulvin, ketoconazole, fluconazole and terbinafine by CLSI M38 A (filamentous fungi), 
M27 A2 (yeasts) broth micro dilution methods. All the isolates were resistant to griseofulvin 
with the MIC50 & MIC 90 as follows 
T.mentagrophyte (n = 14): MIC50 – 8µg/ml and MIC90 – 16µg/ml  
T.rubrum (n = 10): MIC50 - 4µg/ml and MIC90 – 16µg/ml 
Aspergillus spp (n = 3): MIC50 – NIL and MIC90 - 16µg/ml  
Penicillium spp (n = 9): MIC50 – NIL and MIC90 - 16µg/ml.  
Candida albicans was not tested against griseofulvin because of its intrinsic resistance.  
(Ref: Table 14). 
 The MIC50 & MIC 90 of ketoconazole as follows 
T.mentagrophyte (n = 14): MIC50 – 0.12µg/ml and MIC90 – 0.25µg/ml  
T.rubrum (n = 10): MIC50 - 4µg/ml and MIC90 – 8µg/ml 
Penicillium spp (n = 9): MIC50 – 2µg/ml and MIC90 - 8µg/ml 
Candida albicans (n = 9):  MIC50 – 2µg/ml and MIC90 - 8µg/ml 
Aspergillus species was not tested against ketoconazole because of its intrinsic resistance. 
(Ref: Table 15). 
The MIC50 & MIC 90 of fluconazole as follows 
T.mentagrophyte (n = 14): MIC50 – 2µg/ml and MIC90 – 4µg/ml  
T.rubrum (n = 10): MIC50 - 2µg/ml and MIC90 – 8µg/ml 
Penicillium spp (n = 9): MIC50 – NIL and MIC90 - 64µg/ml (resistant) 
Candida albicans (n = 9):  MIC50 – 2µg/ml and MIC90 - 4µg/ml 
Aspergillus species was not tested against fluconazole because of its insignificant in vivo 
activity. (Ref: Table 16). 
The MIC50 & MIC 90 of terbinafine as follows 
T.mentagrophyte (n = 14): MIC50 – NIL and MIC90 – 0.03µg/ml  
T.rubrum (n = 10): MIC50 – 0.06µg/ml and MIC90 – 0.12µg/ml 
Aspergillus spp (n = 3): MIC50 – NIL and MIC90 – 0.03µg/ml 
Penicillium spp (n = 9): MIC50 – NIL and MIC90 – 0.03µg/ml  
Candida albicans (n = 9):  MIC50 – 2µg/ml and MIC90 - 16µg/ml (most of the isolates were 
resistant). (Ref: Table 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table: 1 Age wise distribution of cases 
 
                                 
 
 
 
                                         
              
 
 
                    
 
 
  
 
 
 
           
 
 
 
 
 
 
 
 
 
Table 2: Sex wise distribution of cases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 
 
Frequency 
 
Percentage 
<10 
 
1 
01.20 
11-20 
 
3 
03.50 
21-30 
 
14 
16.50 
31-40 
 
16 
18.80 
41-50 
 
24 
28.30 
51-60 
 
16 
18.80 
>60 
 
11 
12.90 
Total 
 
85 
100 
Sex 
 
Frequency 
 
Percentage 
 
M/F Ratio 
 
2.7:1 
Male 62 
72.95 
 
Female 23 
27.05 
 
Total 85 
100 
 
         
 
 
Table 3: Age & Sex wise distribution of cases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 
 Sex 
Total 
Male Female 
<10 
 
0 
1 1 
11-20 
 
3 
0 3 
21-30 
 
8 
6 14 
31-40 
 
12 
4 16 
41-50 
 
20 
4 24 
51-60 
 
8 
8 16 
>60 
 
9 
2 11 
Total 
 
60 
25 85 
  
 
Table 4: Age & Sex wise distribution of clinical type 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical 
pattern 
<10 11-20 21-30 31-40 41-50 51-60 >60 
 
M 
 
F M F M F M F M F M F M F 
DLSO - - 1 - 6 
1 
 
7 3 12 2 4 5 7 - 
PSO - - - - 1 
1 
 
2 - - - - 2 - - 
SWO - 1 1 - 1 
- 
 
- 1 2 - 2 1 1 2 
TDO - - - - - 
1 
 
1 - 5 - 1 - 1 - 
Paronychia - - 1 - - 
3 
 
2 - 1 2 1 - - - 
Total 0 1 3 0 8 
6 
 
12 4 20 4 8 8 9 2 
  
 
 
Table 5: Clinical types in relation to site of involvement 
 
Clinical 
pattern 
Finger nail Toe nail Both Total % 
P 
value 
DLSO 32 10 
6 
 
48 56.5% - 
PSO 4 2 
- 
 
6 7% - 
SWO 9 3 
- 
 
12 14.1% - 
TDO 6 1 
2 
 
9 10.6% - 
Paronychia 9 1 
- 
 
10 11.8% 0.007 
Total (%) 60 (70.59) 17 (20) 
8 (9.41) 
 
85 - - 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 6: Clinical types in relation to occupation 
 
Clinical 
type 
Occupation 
 
Total 
F 
 
O H S M 
DLSO 19 
16 
 
10 1 2 48 
PSO 2 
 
1 
3 - - 06 
SWO 4 
 
1 
3 1 3 12 
TDO 2 
 
2 
1 - 4 09 
Paronychia 2 
 
2 
4 2 - 10 
Total (%) 
29 
(34.11) 
22 
(25.88) 
 
21 
(24.71) 
4 (4.71) 9 (10.59) 85 
Chi Square 
value 
31.729 - - - - - 
P value 
0.011 
 
- - - - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7: Nail changes in Onychomychosis 
 
Nail changes 
 
N = 85 (%) 
Discolouration 
 
85 (100) 
Subungual  hyperkeratosis 
 
38 (44.7) 
Thickening 
 
19 (22.35) 
Onycholysis 
 
15 (17.65) 
Dystrophy 
 
12 (14.12) 
Paronychia 
 
10 (11.76) 
  
 
 
Table8: Associated skin and systemic diseases in onychomycosis 
 
Disease 
 
Number % 
Chi 
square 
value 
P value 
 
Tenia corporis 
7 8.2% 13.588 0.059 
 
Psoriasis 
2 2.35% - - 
 
Eczema 
1 1.2% - - 
 
Hansen’s disease 
1 1.2% - - 
 
Diabetes mellitus 
1 1.2% - - 
 
SHT 
2 2.35% - - 
 
CKD with CRF 
1 1.2% - - 
HIV 
1 
 
1.2% - - 
 
Total 
16 18.9% - - 
 
 
 
  
 
 
Table9: Microscopy versus culture in Onychomycosis 
Microscopy 
(40% KOH) 
Culture 
Total (%) 
n = 85 Positive (%) Negative (%) 
Positive (%) 29 (34.12) 14 (16.47) 43 (50.59) 
Negative (%) 17 (20) 25 (29.41) 42 (49.41) 
Total (%) 46 (54.12) 39 (45.88) 85 (100) 
 
 
 
Table 10: Microscopy – 40% KOH VS 40% KOH with DMSO 
Technique Positive (%) Negative 
Chi Square 
value 
P value 
40% KOH 43(50.6) 42 (49.4) 0.953 0.294 
40% KOH & 
DMSO 
41 (48.2) 44 (51.8) 0.329 0.588 
 
 
 
 
 
 
 
 
 
  
Table 11: Fungal isolates obtained from nail samples 
Group Species No 
% (n= 85) 
Total 
 
Total % 
 
Dermatophyte 
T.mentagrophyte 14 16.5% 
24 28.3% 
T.rubrum 10 11.8% 
NDM 
Aspergillus niger 2 2.4% 
13 15.3% 
Aspergillus flavus 1 1.2% 
Cladosporium spp 1 1.2% 
Penicillium spp 9 10.6% 
Yeast Candida albicans 9 10.6% 9 10.6% 
No growth - 39 - - 45.8% 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 12: Culture results of onychomycosis according to gender 
Group Species Male (%) Female (%) Total 
Dermatophyte 
T.mentagrophyte 12 (26%) 2 (4%) 14 
T.rubrum 9 (20%) 1 (2%) 10 
NDM 
Aspergillus niger 2 (4%) - 2 
Aspergillus flavus 1 (2%) - 1 
Cladosporium spp 1 (2%) - 1 
Penicillium spp 4 (9%) 5 (10%) 9 
Yeast  Candida albicans 4 (9%) 5 (10%) 9 
Total (%) n = 46  33 (72%) 13 (28%) 46 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 13: Culture results of onychomycosis according to site of involvement 
Group Species Finger 
nail 
Toe nail Both Total 
Dermatophyte T.mentagrophyte 8 
(17.5%) 
4 (9%) 2 (4%) 14 
T.rubrum 6 (13%) 3 (6.5%) 1 (2%) 10 
NDM Aspergillus niger 2 (4%) - - 2 
Aspergillus flavus 1 (2%) - - 1 
Cladosporium spp 1 (2%) - - 1 
Penicillium spp 8 
(17.5%) 
1 (2%) - 9 
Yeast Candida albicans 9 (20%) - - 9 
Total (%)n =46  35 (76%) 8 
(17.5%) 
3 (6.5%) 46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
ANTIFUNGAL SUSCEPTIBILITY TESTING OF ISOLATES BY BROTH 
MICRODILUTION METHOD – MIC DETERMINATION 
 
Table 14:  MIC values of Griseofulvin for the isolates 
 
 
 
 
 
 
 
 
 
Isolate 
Concentration of drug (µg/ml) 
M
IC
 5
0
 
M
IC
 9
0
 
0
.0
3
 
0
.0
6
 
0
.1
2
 
0
.2
5
 
0
.5
 
1
 
2
 
4
 
8
 
1
6
 
T.mentagrophyte n = 
14 
8 16 - - - - - - - 1  2 11 
T.rubrum n= 10 4 16 - - - - - 1 1 2 4 2 
Aspergillus spp n = 3 - 16 - - - - - - - - - 3 
Penicillium spp n = 9 - 16 - - - - - - - - - 9 
  
Table 15: MIC values of Ketoconazole for the isolates 
                   
Table 16: MIC values of Fluconazole for the isolates 
  
 
Isolate 
Concentration of drug (µg/ml) 
M
IC
 5
0
 
M
IC
 9
0
 
0
.0
3
 
0
.0
6
 
0
.1
2
 
0
.2
5
 
0
.5
 
1
 
2
 
4
 
8
 
1
6
 
T.mentagrophyte 
n=14 
0.12 0.25 - 3 4 4 1 2 - - - - 
T.rubrum n=10 4 8 - - - - - - 1 5 4 - 
Penicillium spp n = 9 2 8 - - - - - 1 4 1 2 1 
Candida albicans n 
= 9 
2 8 - - - - - 1 5 1 2 - 
Isolate 
Concentration of drug (µg/ml) 
M
IC
 5
0
 
M
IC
 9
0
 
0
.1
2
 
0
.2
5
 
0
.5
 
1
 
2
 
4
 
8
 
1
6
 
3
2
 
6
4
 
T.mentagrophyte n = 14 2 4 - - 2 2 3 5 2 - - - 
T.rubrum n= 10 2 8 - - - - 5 1 3 1 - - 
Penicillium spp n = 9 - 64 - - - - - - - - 1 8 
Candida albicans n = 9 2 4 - 1 1 2 1 3 1 - - - 
  
 
Table 17: MIC values of Terbinafine for the isolates 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Isolate 
Concentration of drug (µg/ml) 
M
IC
 5
0
 
M
IC
 9
0
 
0
.0
3
 
0
.0
6
 
0
.1
2
 
0
.2
5
 
0
.5
 
1
 
2
 
4
 
8
 
1
6
 
T.mentagrophyte n = 14 - 0.03 12 2 - - - - - - - - 
T.rubrum n= 10 0.06 0.12 1 4 4 1 - - - - - - 
Aspergillus spp n = 3 - 0.03 3 - - - - - - - - - 
Penicillium spp n = 9 - 0.03 8 1 - - - - - - - - 
Candida albicans n=9 2 16 - - - - - - 4 1 1 3 
  
Table18: Susceptibility data of the isolates for four drugs – Griseofulvin, Ketoconazole, 
Fluconazole, Terbinafine 
 
  
  
 
  
  
 
 
 
 
Drugs 
 
 
 
 Isolates 
MIC 
(µg/ml) 
T.mentagro 
phyte 
T.rubrum Aspergillus Penicillium Candida 
Griseofulvin 
Range 4 - 16 1 – 16 ≥ 16 ≥ 16 - 
MIC50 8 4 - - - 
MIC90 16 16 16 16 - 
Ketoconazole 
Range 0.06 – 1 2 – 8 - 1 – 16 1 – 8 
MIC50 0.12 4 - 2 2 
MIC90 0.25 8 - 8 8 
Fluconazole 
Range 0.5 – 8 2 - 16 - ≥ 64 0.25 – 8 
MIC50 2 2 - - 2 
MIC90 4 8 - 64 4 
Terbinafine 
Range 0.03 – 0.06 0.03 – 0.12 ≤ 0.03 0.03 – 0.06 2 – 16 
MIC50 - 0.06 - - 2 
MIC90 0.03 0.12 0.03 0.03 16 
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DISCUSSION 
 Onychomycosis is a common infection of nails in adults accounting for the prevalence 
rate of 2 to 50% worldwide and the incidence increases with age
48
. Various studies from 
different geographical locations, the incidence of fungal aetiology in clinically pre diagnosed 
cases of onychomycosis were 43.7% in Poland, 50.6% in Turkey and 43.53% in India.
48, 49,  
 
 In this study, the incidence of onychomycosis was confirmed in 54.12% of clinically 
diagnosed cases, which is slightly higher than those from more recent Indian studies. Das et 
al, from Kolkata in 2008 had reported an incidence of 51.76% and Sarma et al from New 
Delhi had reported even lesser incidence of onychomycosis (32.7%).
15, 21
 On the other hand, 
higher incidence of onychomycosis had also been observed in various countries including 
India. Pontes et al in Brazil reported 66.5% of confirmed cases and a study by Adhikari et al 
in 2009 from Sikkim, India showed the incidence  of 82.35%.
20, 51 
 
  The slight increase in the incidence of onychomycosis in this study may be attributed 
to the changing epidemiological factors such as age, social class, occupation, living 
environment, immuno compromised states etc.  
 
 The commonest age group affected in this study was 41 -50 years (28.30%) followed 
by 31 – 40 years and 51 – 60 years (each constituting 18.80%). So 70% of patients were 
between the age group of 31 – 60 years which is in accordance with studies 
8, 10, 11
by Andre J 
et al, RSN Brilhante et al and by Gupta et al. The increase in cases with this age group may 
be justified by repeated nail micro – trauma due to a more prolonged exposure to pathogenic 
fungi as well as greater work activity and venous insufficiency in this age group.
52, 53
 
Onychomycosis is uncommon before puberty and the lowest incidence in the present study, 
was found in <10years of age, 1% which was the same observed in most of the studies.
7, 15, 16, 
19 
  In the present study men were more commonly affected than women, the ratio being 
2.7:1 which compares well with most of the other studies.
17, 19, 22 
this may be because men are 
more exposed to out door works with greater physical activity and are more prone to trauma. 
However, there have been few studies where men and women are equally affected
21
 and even 
with female predominance.
10 
 
 Various authors and literatures have documented high incidence of onychomycosis in 
toe nails.
2, 4, 20, 31
In the present study, finger nails were involved more than toe nails with the 
ratio of 3:1, which was comparable with other studies.
15, 17, 22
Incidence of increased finger 
nail onychomycosis in this study could be because of the increased chances of occupation 
related trauma, also finger nail infection makes the patient to seek medical attention than toe 
nails. 
 
 Similar to previous studies, DLSO was the most common clinical type in this study 
too. The second common clinical presentation was WSO type which is in agreement with 
Arun Agarwalla et al
54
 and Vinod et al
55
 studies. Gupta et al
19
 had reported the candidal 
onychomycosis as the second common clinical type. There was one HIV positive patient who 
had the clinical type, TDO in this study which is similar to Gupta et al study. There was 
significant association between fingernail involvement and the Paronychia clinical type (P 
value = 0.007, i.e., < 0.05). 
 
 Regarding occupation, the majority of patients in the present study were farmers (29, 
34.11%) followed by office workers (22, 25.88%) and house wives (21, 24.71%). Gupta el 
al
19
 from Shimla had reported similar observation in his study. High incidence among these 
occupational groups is explained by occupation related trauma, increased perspiration and 
frequent exposure to soil saprophytes. Office workers are educated people who are more 
concerned about cosmetic and health consciousness so that they could easily access to health 
care system. There was significant association between the occupation (farmers) and 
onychomycosis (P value = 0.01 i.e., <0.05) 
 
 Direct microscopy (40%KOH) and the fungal culture together remains the gold 
standard mycological techniques used in the diagnosis of onychomycosis.
57
 Among various 
studies.
7, 15, 19, 21
 microscopic positivity and culture positivity results ranged from 33% - 82% 
and 37% - 95% respectively. In this study, direct microscopy was positive in 50.59% of cases 
and the culture was positive in 54.12% of cases which fell within the ranges of other studies.  
 
 The two microscopic techniques had almost equal sensitivity of 50.6% (KOH alone) 
and 48.2% (KOH with DMSO) respectively except the advantage of DMSO in that it gave 
results in one hour. The P value for both the techniques were greater than 0.05. 
 
 The commonest fungi isolated in this study was dermatophytes, 24 (28.3%, n = 85) 
followed by Non dermatophytic moulds (NDM), 13 (15.3%). Yeast constituted 9 (10.6%) all 
of which were Candida albicans. Veer et al
17
 in 2006 from Aurangabad, India had reported 
the similar findings with dermatophytes, 29.5%. However, in his study the NDM and Yeasts 
constituted only 13% and 5.6% respectively. The isolation rate of Yeast and NDM was found 
to be 5 – 40% and 5 – 35% respectively from various studies.
7,
 
14, 20, 21
 Candidal 
onychomycosis is commonly associated with finger nail onychomycosis that too in female 
patients.
14
 Here in this study, however there was no significant association between the 
Candidal onychomycosis and the female patients (P value = 0.085). 
 
 Among the species, T.mentagrophyte was the commonest species isolated (14) in this 
study which is comparable with the Kaur R et al
30
, Grover C et al
56
 studies from New Delhi 
and Arun Agarwalla et al
54
 study from Nepal. M. Gerami shoar et al
14
 from Iran had observed 
similar finding in his study. T. rubrum was the second common isolate(10) in the present 
study. Veer et al
17
, Das et al
19
 and various other authors from different parts of India
19, 22
 had 
reported T.rubrum as the first common species. However, Adhikari et al
20
 from Sikkim had 
reported T. tonsurans (44.44%) as the commonest species. 
 
 In this study there was significant number (9, 10.6%) of Penicillium species among 
the NDM which is in contrast with most of the other studies
17, 21, 22
where Aspergillus species 
was the common NDM. Other NDM isolated here were Aspergillus niger (2, 2.4%), 
Aspergillus flavus (1, 1.2%) and Cladosporium (1, 1.2%). However Adhikari et al from 
Sikkim had also reported significant number (14.29%) of Penicillium species in his study. 
 
 Regarding Candidal onychomycosis, it was commonly found among females in 
various studies. 
7, 54
 In this study too female predominance was observed, in whom most of 
them were house maids. This may be attributed to higher contact time with water in those 
patients. 
 
 In the present study, 16 patients (18.9%) had other associated skin diseases like Tenia 
Corporis, Eczema, Psoriasis and systemic diseases like SHT, HIV, CRF  Among the other 
dermatological infections Tenia corporis (7, 8.2%) was seen as the commonest one. The 
association between onychomycosis and the Tenia corporis was just significant (P value = 
0.05). So in those patients, the nail infection could serve as the chronic reservoir for the skin 
infection. S. Neupane et al had recorded 58.2% of onychomycosis was accompanied by 
superficial fungal infection at other sites, Tenia pedis (25.3%) being the most common 
infection. 
 
 
 
ANTIFUNGAL SUSCEPTIBILITY TESTING (CLSI BROTH MICRODILUTION 
METHOD M38 A & M27 A2) 
 Antifungal susceptibility testing of the isolates was done for four drugs namely, 
Griseofulvin, Ketoconazole, Fluconazole and Terbinafine by using CLSI M38 A and M27 A2 
protocols (Espinel Ingroff) for filamentous fungi and yeast respectively. In the present study, 
the MIC range, MIC50 and MIC90 of Griseofulvin to the dermatophytes was 1 - 16µg/ml, 
4µg/ml and 16µg/ml.  In contrast, a study by M.E.S. Barros et al
59
, 2006 showed the values 
were 0.062 -1 µg/ml, 0.5 µg/ml and 0.25 µg/ml respectively. A study by Ghannoum et al, 
2004
60
 showed the MIC range as 0.125 – 64 µg/ml. 
 
For the Aspergillus species and Penicillium species the MIC90 of Griseofulvin was 
16µg/ml. Develoux
61
 and Artis et al
62
 considered isolates resistant to Griseofulvin when MIC 
values were equal or greater than 3 µg/ml. According to this standard our findings suggest 
that all the isolates showed in vitro resistance to Griseofulvin. (MIC90 - 16µg/ml). 
 
 
 The MIC range, MIC50 and MIC90 of ketoconazole for dermatophytes were 0.06 – 8 
µg/ml, 0.12 µg/ml and 8 µg/ml respectively. These findings correlated with A. K. Gupta and 
Kohli et al study
63
 where the values were 0.06 – 8 µg/ml, 0.125 µg/ml and 2 µg/ml. MIC 
range, MIC50 and MIC90 for Penicillium species were 1 – 16  µg/ml, 2 µg/ml and 8 µg/ml in 
this study. For Candida albicans the values were 1 – 8 µg/ml, 2 µg/ml and 8 µg/ml which 
were close to A. K. Gupta and Kohli et al study
63
 where the MIC50 was 1 µg/ml. 
 
 The MIC50 and the MIC90 of fluconazole for dermatophytes in this study were 2 
µg/ml and 8 µg/ml which varied from other studies,
 59, 64, 67
 where the MIC50 and MIC90 
were high (16 µg/ml and 32 µg/ml). This variation may be influenced by inoculum size for 
the azole group of drugs.
65
 Fluconazole gave highest MIC90 for all Penicillium species in this 
study which was 64 µg/ml. Candida albicans MIC range, MIC50 and MIC 90 were 0.25 – 8 
µg/ml, 2 µg/ml and 4 µg/ml respectively which was similar to the values observed in Pfaller 
et al
66
study (MIC90 - ≤8 µg/ml). 
 
 Terbinafine showed the lowest MIC value (≤0.03 µg/ml) for all the isolates tested 
except for Candida albicans to which it showed variable sensitivity (MIC range: 2 -16 µg/ml). 
These findings compare well with all the other studies.
59, 60, 64  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
• This prospective study was conducted over a period of 15 months and the study 
population comprised of 85 clinically diagnosed cases of onychomycosis. 
• There were 62 cases of Men and 23 cases of Women with a ratio of 2.7:1. 
• Most of the cases occurred in the age group range 31 – 60years. 
• Lowest incidence of the disease was observed in less than 20years of age group 
(4.7%). 
• The commonest clinical pattern was DLSO (57%) and the less common type was PSO 
(7%). 
• One HIV patient on ART had TDO type of onychomycosis with all nail units 
affected. The isolate obtained from this patient was T.mentagrophyte. 
• Finger nails (70%) were commonly affected than toe nails (20%) with a ratio of 3.5:1. 
• The commonly affected occupational group were farmers followed by office workers 
and house wives. All of them had significant fingernail involvement. 
• The associated other skin and systemic diseases were seen in small number of patients 
(18.9%) 
• Direct microscopy was able to detect fungal elements in 43 cases (50.59%) and the 
culture was positive in 46 cases (54.12%) 
• Group of fungi involved in these cases were Dermatophytes, Non Dermatophytic 
moulds and the Yeast. 
• T.mentagrophyte was the commonest species among dermatophytes and Penicillium 
species was the common isolate among NDM, while all the Yeasts were Candida 
albicans. 
• Anti fungal susceptibility testing of the isolates was done by CLSI broth micro 
dilution method (M38 A & M27 A2). 
• MIC50, MIC90 was obtained for four drugs namely, Griseofulvin, Ketoconazole, 
Fluconazole and Terbinafine. 
• All the isolates were resistant to Griseofulvin with the MIC 16 µg/ml. 
• All the isolates were sensitive to Terbinafine, Ketoconazole, Fluconazole with the 
exception of Penicillium species showing resistant to Fluconazole. 
• Among all the drugs tested, Terbinafine showed the lowest MIC, ≤0.03 µg/ml for all 
the isolates except for Candida albicans. 
• For all the filamentous fungi, Terbinafine was the best drug with highest in vitro 
activity. 
• Fluconazole was the better choice for Candida albicans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 The findings in this study revealed that onychomycosis is an important health problem 
in Coimbatore district, South India and the epidemiological pattern of the disease varied from 
other parts of the country. The same clinical type of disease yielded different fungal species 
in culture so that type of nail changes cannot be taken as a reliable marker for predicting the 
causative agent and thus the study stresses the need for microbiological confirmation in case 
of onychomycosis.  
 
The sensitivity of direct microscopy and culture together for onychomycosis in this 
study was 70.58% when compared to Microscopy (51%) or culture (54%) alone. So this 
study concludes that direct microscopy should always be coupled with fungal culture for the 
accurate diagnosis and species identification to carry out the appropriate treatment for this 
chronic relapsing disease.  
 
The CLSI broth microdilution method (M38 A & M27 A2) was used for in vitro 
susceptibility testing of the isolates because of its reproducibility, reliability and user friendly 
nature. The in vitro data obtained in this study indicates that the terbinafine is the most potent 
of all antifungal agents with lowest MIC to treat all filamentous fungi, both the 
dermatophytes and the non dermatophytic moulds causing onychomycosis which is further 
confirmed by other studies, 
39
 the relatively high clinical cure (in vivo activity) rate of 80- 
90% for finger nail infections and 70 – 80% for toe nail infections.
  
 
 
 
 
 
 
 
 
 
The results also suggest that the best drug for treating Candidal onychomycosis is 
fluconazole. The griseofulvin, which has been extensively used to treat superficial fungal 
infections including onychomycosis in our clinical setting showed the highest MIC 
(≥16µg/ml) in the present study which correlated well with the poor clinical outcome. This 
study also stresses that the Penicillium species is the significant NDM causing 
onychomycosis in this area and all the Penicillium isolates showed in vitro resistance to 
fluconazole (MIC ≥64µg/ml) in this study. 
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APPENDIX 
1) PREPARATION OF 40% KOH: 
Potassium hydroxide - 40 gm 
Distilled water - 100 ml 
Add Potassium hydroxide crystals to distilled water slowly and with stirring mix by stirring 
until the crystals are dissolved.  
2) PREPARATION OF 40% KOH with DMSO: 
Potassium hydroxide - 40 gm 
Dimethyl sulphoxide – 40ml 
Distilled water - 60 ml 
 Add Potassium hydroxide crystals to distilled water slowly and with stirring mix by stirring 
until the crystals are dissolved. Then add 40ml 0f DMSO in to that solution and mix well. 
3. LACTOPHENOL COTTON BLUE: 
Phenol - 20 gm 
Lactic acid - 20 ml 
Glycerol - 40 ml 
Distilled water - 20 ml 
Cotton blue - 0.075 gm 
Add Lactic acid and glycerol to distilled water. Mix well. Add phenol crystals and dissolve 
by gentle heating. Add cotton blue and dissolve thoroughly.  
The phenol acts as disinfectant, Lactic acid preserves the morphology of the fungi and 
glycerol is hygroscopic agent which prevents drying. The cotton blue stains the outer wall of 
the fungus.  
 
 
4. SABOURAUD’S DEXTROSE AGAR: 
Dextrose - 40 g 
Peptone (mycological) - 10 g 
Agar - 20 g 
Distilled water - 1000 ml 
(65 grams of dehydrated media should be reconstituted in 1 litre of distilled water). 
Dissolve the powder in distilled water by boiling. Adjust the pH to 5.4. Autoclave at 121°C 
for 15 minutes at 15 lbs. Dispense in tubes and in Petri dishes. Allow the tubes to cool in 
slanting position. Store it in refrigerator.  
5. SABOURAUD’S DEXTROSE AGAR WITH CHLORAMPHENICOL AND 
CYCLOHEXIMIDE:  
Dextrose - 40 g 
Peptone (mycological) - 10 g 
Agar – 20 g  
Chloramphenicol – 50 mg 
Cycloheximide – 500 mg 
Prepare Sabouraud’s dextrose agar by dissolving the ingredients in distilled water as 
explained above. Dissolve 50 mg of chloramphenicol in 10 ml of 95% alcohol and 500 mg of 
cycloheximide in 10 ml of acetone and add to the boiling medium. Remove from heating and 
mix well. Dispense in tubes and autoclave at 121°C for 15 minutes.  
6. POTATO DEXTROSE AGAR: 
Potato: 200g 
Dextrose: 20g 
Agar: 20g 
Water: 1 lit 
Scrub but do not peel the potato & cut into 12 ml cubes, Boil 200g in 1 lit of water for 
60 minutes. Squeeze as much of the pulp as possible through a fine sieve. Add agar and 
boiled till dissolved. Add dextrose and make up to 1 liter. Dispense in required amounts 
taking care to keep solids in suspension. Autoclave at 115° C for 30 minutes. Cool to 50° C 
& pour in to tubes and allowed to cool in slanted position.  
7. CHRISTENSEN’S UREA MEDIUM: 
Peptone: 1.0g 
NaCl: 5.0g 
KH2 PO4: 2.0g 
Glucose: 5.0g 
Agar: 20.0g 
Distilled water: 1000ml 
After dissolving the above ingredients by heat 5ml of phenol red solution (0.2% in 50 % 
alcohol) was added after which autoclaved at 115° centigrade per 15 minutes. On 
cooling 100ml of urea (20% aqueous solution sterilized by filtration) is added medium is 
poured into slopes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
 
 
 
NAME:                                                               AGE/SEX:                          OP NO: 
 
 
ADDRESS/LOCALITY:                                                                                 DATE: 
 
 
 
 
 
 
SOCIO-ECONOMIC STATUS: 
 
Educational level: 
Occupation          : 
Living condition   : 
Others                 : 
 
PERSONAL HISTORY: 
 
 
 
PAST HISTORY: 
 
 
TREATMENT HISTORY, IF ANY: (In the past) 
 
 
PRESENTING COMPLAINTS (WITH DURATION): 
  
 
 
 FIRST EPISODE:                                                            
 
 
LOCAL EXAMINATION OF INFECTED SITE:( NAIL)  
 
a) FINGER NAIL/TOE NAIL 
 
b) SITE : 
 
i) Colour :              ii)Texture :                 iii)Nail plate :                 iv) Nail bed : 
 
v) Subungual hyperkeratosis :                                               vi) Onycholysis : 
 
  
CLINICAL DIAGNOSIS : 
 
 
TREATMENT: 
 
FOLLOW UP: Completely resolved/Partially resolved/Not resolved 
WORK SHEET 
 
1) CLINICAL SAMPLE: Nail clippings/ scrapings 
 
2) KOH WET MOUNT:    
          i)YEAST CELLS:                          
          ii) HYPHAE        : Septate, Branched hyphae- Mild/moderate/more 
                                         Spores, if any 
                                         Pigmentation, if any 
 
3) CULTURAL ISOLATION (IN DUPLICATES)                             AT 25-30ºC 
                                                                            
 
 
3a) SDA WITH ANTIBIOTICS & ANTIFUNGALS                      
( Cycloheximide + Chloramphenicol) 
Growth characteristics: 
                                                   
                                                                                          AT 25-30ºC (NDM) 
 
3b) SDA WITH ANTIBIOTIC (NDM) 
 Growth characteristics: 
                                                                            
 
3c) SDA WITH ANTIBIOTIC (CANDIDA SPP) at 37ºC, 24-48hrs: 
Growth characteristics: 
 
4) SPECIES IDENTIFICATION: LPCB mount, Special tests (Urease test, Slide culture, etc) 
                                                       Candida spp – Grams stain, Germ tube test 
 
MYCOLOGICAL DIAGNOSIS: 
 
 
5) ANTI FUNGAL SUSCEPTIBILITY TESTING (CLSI M-38 A2 & M27 A2) 
 
                                          Detection of MIC – Microbroth dilution Technique 
                                                                                                                                                         
                                                                       MIC µg/ml          Interpretation(R/I/S)     
                                
                               
                               Griseofulvin 
 
                              Ketaconazole 
                                 
                                Fluconazole 
 
                                Terbinafine 
 
  
 
 
1 wk 2 wks 3 wks 4 wks 
 
 
   
1
 
wk 2 wks 3 wks 4 wks 
 
 
   
 
 
 
 
 
 
 
 
                                                      
 
S.No NAME OP NO AGE/ SEX OCCUPATION 
CLINICAL DIAGNOSIS MYCOLOGICAL DIAGNOSIS 
Type Site 40%KOH 
40%KOH 
&DMSO 
Culture 
1 Thirumoorthi 425867 37/M O C/c paronychia FN Rt - - Candida 
2 Sivasamy 110113 42/M F DLSO TN B/L + + - 
3 Gurunathan 12605 42/M F DLSO FN B/L + - T.rubrum 
4 Dhivakaran 80028 63/M F DLSO TN Rt + + T.rubrum 
5 Devaraj 117878 30/M F 
DLSO/ 
T.corporis 
TN Rt + + 
T.mentagro
phyte 
6 Thirupathi 163078 30/M O 
DLSO/ 
T.corporis 
TN Lt + - - 
7 Balamani 123585 58/F H PSO FN Rt - - Candida 
8 Subbaiya 170622 62/M F 
.DLSO/ 
T.corporis 
FN B/L + + - 
9 Thulasimani 300904 22/F H DLSO TN Rt - - - 
10 Kumar 302658 29/M O PSO FN Rt - - A.niger 
11 Ramaraj 400987 60/M F C/c paronychia TN B/L - - Candida 
12 Nallasamy 6435/09 65/M M DLSO FN B/L + + A.flavus 
13 Subbaiya 470572 65/M F DLSO FN B/L - - 
T.mentagro
phyte 
14 Pattiyappan 180253 65/M F C/c paronychia FN Rt + - Candida 
15 Prakasam 502617 30/M O DLSO FN Rt - - - 
MASTER CHART  
16 Iyyammal 515232 52/F H DLSO 
FN & 
TN B/L 
+ + T.rubrum 
17 V.Ramani 515278 43/M O SWO TN Rt + + - 
18 Nataraj 256524 65/M O DLSO FN Rt + + - 
19 Nagalingam 206718 40/M M DLSO FN Lt + + 
T.mentagro
phyte 
20 Mallika 528627 30/F H TDO/Onycholysis FN/B/L + + Penicillium 
21 Murugasen 54290 39/M O DLSO FN Rt + + T.rubrum 
22 Kalaiyarasi 54382 6/Fch M SWO FN Lt + + - 
23 Sadikbasha 568796 45/M M TDO/Onycholysis FN B/L + + Penicillium 
24 Thirumathal 14790 55/F H DLSO FN/B/L - - 
T.mentagro
phyte 
25 Ushainbeevi 435233 58/F H DLSO FN Rt + + Penicillium 
26 Sivasamy 549253 47/M M TDO/Hansen’s dis FN B/L + + 
T.mentagro
phyte 
27 Lakshmi 586907 30/F H C/c paronychia FN Rt - - - 
28 Palanisamy 586958 43/M O DLSO FN Rt + + - 
29 Kumar 629523 18/M S SWO FN Rt - - - 
30 Kannan 629657 52/M O DLSO FN B/L + + - 
31 Rangaraj 557561 46/M F DLSO FN Rt - - - 
32 Susila 5697 60/F H DLSO TN B/L - - 
T.mentagro
phyte 
33 Subbaiya 69007 60/M F 
DLSO/Eczema 
of hands & legs 
FN & 
TN B/L 
+ + - 
34 Rajamani 1698 50/F H C/c paronychia FN Rt - - Candida 
35 Shanmugam 205410 45/M F DLSO/Psoriasis/DM FN B/L - - T.rubrum 
36 Ravi kumar 21199 26/M M SWO/CKD/CRF FN B/L + + 
Cladospori
um 
37 Balraj 700491 40/M F DLSO FN B/L - - - 
38 A.Nataraj 710139 40/M O TDO TN Rt - - 
T.mentagro
phyte 
39 Raman 711453 50/M F DLSO FN Lt + + - 
40 Selvi 725441 30/F H PSO FN Rt + + - 
41 Gopal 734824 50/M F DLSO FN B/L + + 
T.mentagro
phyte 
42 Palanisamy 734666 40/M O 
DLSO/ 
T.corporis 
FN Rt - - - 
43 Ganesh 734325 30/M O DLSO FN Lt - - - 
44 Venkatachala 736571 50/M O C/c paronychia FN B/L - - Candida 
45 Kunjammal 749690 45/F H DLSO FN B/L - - - 
46 Mery 720420 54/F H DLSO FN B/L + + Penicillium 
47 Mohammad 720414 52/M M TDO/onycholysis FN B/L - - T.rubrum 
48 Mariyappan 8990 35/M F PSO/onycholysis FN Rt + + Candida 
49 Uthramoorthy 769832 33/M O DLSO FN Lt + + 
T.mentagro
phyte 
50 Shanmugam 769910 65/M F DLSO FN Rt - - - 
51 Palanisamy 769928 45/M O DLSO FN Rt - - T.rubrum 
52 Rangasamy 776514 65/M F DLSO FN Lt + + - 
53 Karupusamy 779400 60/M F SWO FN Lt + + A.niger 
54 Ramesh 780188 19/M S DLSO TN Rt - - - 
55 Papathi 79522 65/F F SWO/SHT/RA TN B/L - - - 
56 Arumugam 506309 60/M F DLSO/T.corporis TN B/L + + T.rubrum 
57 Raguram 79540 50/M F DLSO FN Lt - - - 
58 Kannammal 541/10 65/F H SWO FN Rt + + Penicillium 
59 Kokila 575644 48/F H DLSO FN B/L - - - 
60 Amudhavalli 57341 52/F H SWO FN Rt + + Penicillium 
61 Rathinum 201234 57/F H PSO FN B/L - - Candida 
62 Raheem 34212 30/M O 
DLSO/ 
T.corporis 
TN Rt - - 
T.mentagro
phyte 
63 Sulochana 58356 47/F H Paronychia FN Rt - - Candida 
64 Sangeetha 81589 21/F S Paronychia FN B/L + + Candida 
65 Arulsamy 65910 64/M F SWO TN Rt + + Penicillium 
66 Kamatchi 82483 39/F H DLSO FN Rt - - - 
67 Rajendran 52604 46/M M SWO/SHT/Psoriasis FN B/L - - - 
68 Aelumalai 58666 27/M F DLSO FN Rt + + 
T.mentagro
phyte 
69 Nataraj 78077 65/M F TDO FN B/L - - - 
70 Shanthamani 735776 38/F H DLSO FN B/L - - - 
71 Palanisamy - 36/M F PSO TN B/L + + - 
72 Josaphwilson - 42/M O TDO 
FN & 
TN B/L 
+ + 
T.mentagro
phyte 
73 Maragatham 14660 35/F H SWO FN Lt - - - 
74 Senthilkumar 51381 42/M O DLSO TN B/L + + - 
75 Riyastha 743841 26/F H Paronychia FN Rt - - - 
76 Thangavel 7853 56/M F DLSO TN B/L - - T.rubrum 
77 Chenniyappan 18401 45/M F TDO FN Rt + + 
T.mentagro
phyte 
78 Kandhasamy 167352 60/M F SWO FN Lt - - - 
79 Kaalisamy 642042 55/M F DLSO FN Rt - - - 
80 Ganesh 17500 37/M O 
DLSO/Tenia 
corporis 
FN B/L - - T.rubrum 
81 John wilson 1862/10 45/M M AIDS/TDO 
FN & 
TN B/L 
+ + 
T.mentagro
phyte 
82 Balakumar 1802 19/M S Paronychia FN B/L + + Penicillium 
83 Dhakshinamoorthy 18659 45/M F DLSO 
FN & 
TN B/L 
- - - 
84 Udhayakumar 154551 35/M O DLSO FN Rt + + Penicillium 
85 Sivakumar - 37/M O DLSO FN Rt - - - 
   KEY TO MASTER CHART 
 
 Sex: 
                    M – Male 
                     F - Female 
Occupation:  
                    F – Farmer 
                    O – Office worker 
                    H – House wife 
                    S – Student 
                    M – Miscellaneous  
Site:  
                   FN – Fingernail 
                   TN – Toe nail 
                    Rt - Right side 
                    Lt – Left side 
                    B/L - Bilateral 
                    
 
 
 
 
 
 
 
 
 
